Cargando…
Clinical Impact on Tuberculosis Treatment Outcomes of Discordance Between Molecular and Growth-Based Assays for Rifampin Resistance, California 2003–2013
Background. Data from international settings suggest that isolates of Mycobacterium tuberculosis with rpoB mutations testing phenotypically susceptible to rifampin (RIF) may have clinical significance. We analyzed treatment outcomes of California patients with discordant molecular-phenotypic RIF res...
Autores principales: | Shah, Neha S., Grace Lin, SY, Barry, Pennan M., Cheng, Yi-Ning, Schecter, Gisela, Desmond, Ed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5047429/ https://www.ncbi.nlm.nih.gov/pubmed/27704008 http://dx.doi.org/10.1093/ofid/ofw150 |
Ejemplares similares
-
Use of Nucleic Acid Amplification Tests in Tuberculosis Patients in California, 2010–2013
por: Peralta, Gianna, et al.
Publicado: (2016) -
Death With Tuberculosis in California, 1994–2008
por: Pascopella, Lisa, et al.
Publicado: (2014) -
Assessing Complexity Among Patients With Tuberculosis in California, 1993–2016
por: Vaisman, Alon, et al.
Publicado: (2020) -
Discordance in Mycobacterium tuberculosis Rifampin Susceptibility
por: Kalokhe, Ameeta S., et al.
Publicado: (2012) -
Interferon-γ Release Assay Performance in Pediatric Tuberculosis Disease in California
por: Kay, Alexander, et al.
Publicado: (2017)